1257: Kratom | Skeptical Sunday

Key Takeaways Copied to clipboard!

• Kratom, a plant in the coffee family, exhibits dual effects, acting as a mild stimulant at low doses and a legal, light opioid at higher doses by interacting with both adrenergic and opioid receptors.  Copied to clipboard!
• The scientific understanding of Kratom is severely limited due to a lack of long-term, high-quality, double-blind studies, relying instead on self-reporting and anecdotal evidence regarding its use for pain management and opioid withdrawal.  Copied to clipboard!
• Despite FDA and DEA concerns, Kratom remains largely legal in the US, often labeled 'Not for Human Consumption' as a regulatory loophole, and its potential benefit as a less lethal alternative to hard opioids like fentanyl is a significant factor in its continued use.  Copied to clipboard!

Segments Expand All Collapse All

Kratom’s Dual Effects Explained

Copied to clipboard!

(00:04:15)

• Key Takeaway: Kratom acts as a stimulant at low doses by binding to adrenergic receptors, but shifts to an opioid-like depressant effect at higher doses by binding to opioid receptors.
• Summary: Kratom is botanically related to the coffee plant, causing stimulation, focus, and energy at lower doses. At higher doses, it acts like a legal, light opioid, causing drowsiness and potentially a ’nod.’ This dual effect is determined by which brain receptors (adrenergic vs. opioid) the alkaloids bind to more strongly based on dosage.

Historical Use and Modern Forms

Copied to clipboard!

(00:08:48)

• Key Takeaway: Western consumption of concentrated Kratom extracts is significantly more potent and potentially dangerous than the traditional chewing of leaves by Southeast Asian laborers.
• Summary: Kratom has been used for thousands of years in Thailand and Indonesia by manual laborers chewing the leaves for stamina. Western consumption often involves concentrated forms like powders or extracts, which is analogous to the difference between drinking coca leaf tea and consuming cocaine. Thailand recently legalized its use for medicinal purposes only after a decades-long ban.

Market Size and Anecdotal Uses

Copied to clipboard!

(00:12:28)

• Key Takeaway: The US Kratom market is valued at over $2 billion annually, with users claiming benefits ranging from energy enhancement to managing anxiety and opioid withdrawal.
• Summary: The US Kratom market generates over $2 billion yearly, though this is small compared to legal cannabis sales. Users present conflicting narratives, with some genuinely using it for chronic pain or anxiety, while others may use higher doses simply to get high. The host notes that switching from highly lethal opioids like fentanyl to Kratom is preferable to death.

Kratom’s Mechanism of Action

Copied to clipboard!

(00:06:52)

• Key Takeaway: Kratom’s primary active alkaloids, mitragynine and 7-hydroxy mitragynine, interact with opioid receptors (causing drowsiness/pain relief with limited respiratory depression) and adrenergic receptors (causing stimulation).
• Summary: The effects stem from alkaloids interacting with brain receptors. Opioid receptor activation causes drowsiness and pain relief but crucially involves limited respiratory depression, unlike dangerous traditional opioids. Adrenergic receptors account for its stimulating properties, while dopamine and serotonin receptor impacts are poorly understood.

Fentanyl Overdose Crisis Context

Copied to clipboard!

(00:21:58)

• Key Takeaway: Fentanyl overdose is the leading cause of death for Americans aged 18 to 45, claiming over 70,000 lives annually, dwarfing the US death toll from the Vietnam War.
• Summary: Studies show Kratom-only overdose deaths are extremely rare, contrasting sharply with the fentanyl crisis. Over 70,000 people die annually from fentanyl overdoses, which is more than the 58,220 US servicemen who died in the Vietnam War. Listeners are urged to carry Narcan and test street drugs due to fentanyl contamination.

Addiction Profile and Withdrawal Symptoms

Copied to clipboard!

(00:42:56)

• Key Takeaway: Chronic, heavy Kratom use (around 10 grams daily) can lead to addiction characterized by withdrawal symptoms highly similar to opioids, including anxiety, muscle aches, and insomnia.
• Summary: Kratom addiction requires daily large doses, and withdrawal symptoms mirror those of opioids, including anxiety, dysphoria, muscle aches, and tremors, often described as a ‘mini opioid withdrawal.’ Withdrawal onset begins 12 to 24 hours after the last dose and peaks around three days, lasting a week or more. Doctors often fail to take Kratom withdrawal seriously, leaving users to tough it out without formal support systems.

Regulatory History and Legal Status

Copied to clipboard!

(00:30:12)

• Key Takeaway: The DEA attempted an emergency Schedule I ban on Kratom in 2016, but withdrew it due to massive public outcry, leaving the substance in a gray area regulated loosely under the 1994 DSHEA Act.
• Summary: The DEA first flagged Kratom as a drug of concern around 2012, followed by an emergency Schedule I ban proposal in 2016, which was withdrawn after 140,000 signatures opposed it. Kratom is currently regulated under the Dietary Supplement Health and Education Act of 1994, treating it as food rather than a drug, allowing sales without FDA pre-approval if marketed vaguely (e.g., ’elevates mood’).